Prevalence, Awareness, Treatment and Control of Hypertension in Island of China during the 2000s: A Systematic Review_Chinese Journal of Evidence-Based Medicine

Authors：

 CHENXin ^1,2 , ZHOUBo ^1,2 , YANGBo-Wen ^1,2 , WUXiao-Mei ^1,2 , ZOUSa-Feng ³ ,  SHIJing-Pu ^1,2

1. Department of Clinical Epidemiology and Evidence-Based Medicine, the First Alienated Hospital, China Medical University, Shenyang 110001, China;
2. Evidence-Based Medicine Center of Liaoning Province, Shenyang 110001, China;
3. Dalian Central Hospital Affiliated to Dalian Medical University, Dalian 116001, China;

Corresponding?author：

SHIJing-Pu, Email: sjp56@yahoo.com

Keywords：

Hypertension; Prevalence; Island; Systematic review; Meta-analysis; Cross-sectional study

DOI：

10.7507/1672-2531.20150050

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To explore the prevalence, awareness, treatment and control of hypertension in island of China. Methods Literatures regarding the prevalence and treatment of hypertension in island of China were retrieved in PubMed, EMbase, The Cochrane Library (Issue 12, 2013), CNKI, WanFang Data and CBM from January 2000 to December 2012. Two reviewers independently screened literature according to the inclusion and exclusion criteria, and extracted data. Then the pooled rates were conducted by Comprehensive Meta-Analysis software using inverse variance method. Results Nine studies involving 926 836 samples were included. The results of meta-analysis showed the pooled rates of prevalence, awareness, treatment and control were 32.0% (95%CI 18.8% to 48.8%), 47.4% (95%CI 29.7% to 65.8%), 38.0% (95%CI 23.1% to 55.5%) and 10.0% (95%CI 4.3% to 21.7%), respectively. Whether in 60 or 65 as the threshold value, the prevalence of hypertension in old people was higher than that in young people. Conclusion The prevalence of hypertension is about 32% and much higher in island regions of China, while the awareness, treatment and control rates are so lower in these regions. The relevant public health policy should pay more attention to improve primary health care in these regions.

Citation： CHENXin, ZHOUBo, YANGBo-Wen, WUXiao-Mei, ZOUSa-Feng, SHIJing-Pu. Prevalence, Awareness, Treatment and Control of Hypertension in Island of China during the 2000s: A Systematic Review. Chinese Journal of Evidence-Based Medicine, 2015, 15(3): 290-294. doi: 10.7507/1672-2531.20150050 Copy

1.	Ezzati M, Vander Hoorn S, Lawes CM, et al. Rethinking the "diseases of affluence" paradigm:global patterns of nutritional risks in relation to economic development. PLoS Med, 2005, 2(5):e133.
2.	Hu SS, Kong LZ, Gao RL, et al. Outline of the report on cardiovascular disease in China, 2010. Biomed Environ Sci, 2012, 25(3):251-256.
3.	Lenfant C, Chobanian AV, Jones DW, et al. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7):resetting the hypertension sails. Hypertension, 2003, 41(6):1178-1179.
4.	Singer P, Gawellek F, Faulhaber HD, et al. WHO recommendations on the classification of hypertension. Dtsch Gesundheitsw, 1969, 24(17):772-775.
5.	Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology. JAMA, 2000, 283(15):2008-2012.
6.	Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses:the PRISMA statement. Int J Sur, 2010, 8(5):336-341.
7.	王通富, 盛志滿, 黃友賀, 等. 玉環縣沿海村民高血壓調查. 浙江預防醫學雜志, 2001, 13(8):19-20.
8.	張均和, 袁國裕, 阮連生. 舟山市高血壓現況調查及危險因素分析. 中華航海醫學與高氣壓醫學雜志, 2006, 13(2):105-107.
9.	方快發, 吳平生, 包太成, 等. 大亞灣地區海島漁民高血壓流行病學特征及危險因素分析. 中國慢性病預防與控制, 2007, 15(3):271-272.
10.	張乾通, 張均和, 王建躍. 海島居民高血壓流行病學基線調查結果分析. 海峽預防醫學雜志, 2006, 12(6):20-22.
11.	孫喜琢, 王雪, 潘曉芳, 等. 大連市獐子島地區心血管疾病危險因素的流行病學調查. 中國心血管雜志, 2008, 13(4):280-283.
12.	黃志平, 王小華, 林加鋒, 等. 海島居民高血壓患病情況調查分析. 心腦血管病防治, 2009, 9(5):31-33.
13.	Tseng LN, Tseng YH, Jiang YD, et al. Prevalence of hypertension and dyslipidemia and their associations with micro-and macrovascular diseases in patients with diabetes in Taiwan:An analysis of nationwide data for 2000-2009. J Formos Med Assoc, 2012, 111(11):625-636.
14.	周文岳, 李松濤, 劉燦磊, 等. 海島地區 35 歲以上人群高血壓流行病學調查. 心腦血管病防治, 2010, 10(6):455-457.
15.	蔣世振, 朱鵬立, 余鵬, 等. 海島地區居民高血壓患病現狀及影響因素分析. 中國公共衛生, 2013, 29(10):1532-1534.
16.	Wu Y, Huxley R, Li L, et al. Prevalence, awareness, treatment, and control of hypertension in China data from the China National Nutrition and Health Survey 2002. Circulation, 2008, 118(25):2679-2686.
17.	Gu D, Reynolds K, Wu X, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension, 2002, 40(6):920-927.
18.	于有利, 鄧麗娟, 寧新好, 等. 長海縣漁村居民高血壓流行病學調查分析. 中國公共衛生, 1993, 9(10):477.
19.	Xi B, Liang Y, He T, et al. Secular trends in the prevalence of general and abdominal obesity among Chinese adults, 1993-2009. Obes Rev, 2012, 13(3):287-296.
20.	Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension, 2008, 52(5):818-827.
21.	Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension, 2007, 49(1):69-75.
22.	Dickinson HO, Mason JM, Nicolson DJ, et al. Lifestyle interventions to reduce raised blood pressure:a systematic review of randomized controlled trials. J Hypertens, 2006, 24(2):215-233.
23.	He J, Muntner P, Chen J, et al. Factors associated with hypertension control in the general population of the United States. Arch Intern Med, 2002, 162(9):1051.

1. Ezzati M, Vander Hoorn S, Lawes CM, et al. Rethinking the "diseases of affluence" paradigm:global patterns of nutritional risks in relation to economic development. PLoS Med, 2005, 2(5):e133.
2. Hu SS, Kong LZ, Gao RL, et al. Outline of the report on cardiovascular disease in China, 2010. Biomed Environ Sci, 2012, 25(3):251-256.
3. Lenfant C, Chobanian AV, Jones DW, et al. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7):resetting the hypertension sails. Hypertension, 2003, 41(6):1178-1179.
4. Singer P, Gawellek F, Faulhaber HD, et al. WHO recommendations on the classification of hypertension. Dtsch Gesundheitsw, 1969, 24(17):772-775.
5. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology. JAMA, 2000, 283(15):2008-2012.
6. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses:the PRISMA statement. Int J Sur, 2010, 8(5):336-341.
7. 王通富, 盛志滿, 黃友賀, 等. 玉環縣沿海村民高血壓調查. 浙江預防醫學雜志, 2001, 13(8):19-20.
8. 張均和, 袁國裕, 阮連生. 舟山市高血壓現況調查及危險因素分析. 中華航海醫學與高氣壓醫學雜志, 2006, 13(2):105-107.
9. 方快發, 吳平生, 包太成, 等. 大亞灣地區海島漁民高血壓流行病學特征及危險因素分析. 中國慢性病預防與控制, 2007, 15(3):271-272.
10. 張乾通, 張均和, 王建躍. 海島居民高血壓流行病學基線調查結果分析. 海峽預防醫學雜志, 2006, 12(6):20-22.
11. 孫喜琢, 王雪, 潘曉芳, 等. 大連市獐子島地區心血管疾病危險因素的流行病學調查. 中國心血管雜志, 2008, 13(4):280-283.
12. 黃志平, 王小華, 林加鋒, 等. 海島居民高血壓患病情況調查分析. 心腦血管病防治, 2009, 9(5):31-33.
13. Tseng LN, Tseng YH, Jiang YD, et al. Prevalence of hypertension and dyslipidemia and their associations with micro-and macrovascular diseases in patients with diabetes in Taiwan:An analysis of nationwide data for 2000-2009. J Formos Med Assoc, 2012, 111(11):625-636.
14. 周文岳, 李松濤, 劉燦磊, 等. 海島地區 35 歲以上人群高血壓流行病學調查. 心腦血管病防治, 2010, 10(6):455-457.
15. 蔣世振, 朱鵬立, 余鵬, 等. 海島地區居民高血壓患病現狀及影響因素分析. 中國公共衛生, 2013, 29(10):1532-1534.
16. Wu Y, Huxley R, Li L, et al. Prevalence, awareness, treatment, and control of hypertension in China data from the China National Nutrition and Health Survey 2002. Circulation, 2008, 118(25):2679-2686.
17. Gu D, Reynolds K, Wu X, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension, 2002, 40(6):920-927.
18. 于有利, 鄧麗娟, 寧新好, 等. 長海縣漁村居民高血壓流行病學調查分析. 中國公共衛生, 1993, 9(10):477.
19. Xi B, Liang Y, He T, et al. Secular trends in the prevalence of general and abdominal obesity among Chinese adults, 1993-2009. Obes Rev, 2012, 13(3):287-296.
20. Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension, 2008, 52(5):818-827.
21. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension, 2007, 49(1):69-75.
22. Dickinson HO, Mason JM, Nicolson DJ, et al. Lifestyle interventions to reduce raised blood pressure:a systematic review of randomized controlled trials. J Hypertens, 2006, 24(2):215-233.
23. He J, Muntner P, Chen J, et al. Factors associated with hypertension control in the general population of the United States. Arch Intern Med, 2002, 162(9):1051.

Chinese Journal of Evidence-Based Medicine

Prevalence, Awareness, Treatment and Control of Hypertension in Island of China during the 2000s: A Systematic Review

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content